Rare non-wilms' tumors in children

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report our institutional experience of the management of 2 cases of rare non-Wilms' tumors; a rhabdoid tumor in a 17-month old boy and a clear cell sarcoma in a 5-year old girl. The two patients were treated with ifosfamide/carboplatin/etoposide (ICE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and cyclophosphamide/etoposide (CE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and radiotherapy, respectively. Both patients showed full response with no significant adverse events. At 2-year follow up, they are disease and relapse free. Although contemporary treatment regimens are very promising, multicenter collaborative studies are needed in order to define a standard treatment for non-Wilms' tumors. © M. Kourti et al., 2012.

Cite

CITATION STYLE

APA

Kourti, M., Hatzipantelis, E., Zaramboukas, T., Tragiannidis, A., Petrakis, G., & Athanassiadou-Piperopoulou, F. (2012). Rare non-wilms’ tumors in children. Rare Tumors, 4(1), 16–17. https://doi.org/10.4081/rt.2012.e6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free